association of metabolic syndrome with triple-negative breast cancer
Maiti, B, Kundranda, M. N, Spiro, T. P, Daw, H. A
Published in Breast cancer research and treatment (01.06.2010)
Published in Breast cancer research and treatment (01.06.2010)
Get full text
Journal Article
Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)
Kundranda, M., Gracian, A.C., Zafar, S.F., Meiri, E., Bendell, J., Algül, H., Rivera, F., Ahn, E.R., Watkins, D., Pelzer, U., Charu, V., Zalutskaya, A., Kuesters, G., Pipas, J.M., Santillana, S., Askoxylakis, V., Ko, A.H.
Published in Annals of oncology (01.01.2020)
Published in Annals of oncology (01.01.2020)
Get full text
Journal Article
Corrigendum to ‘Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)’: Annals of Oncology, Volume 31, Issue 1, 2020, Pages 79–87
Kundranda, M., Gracian, A.C., Zafar, S.F., Meiri, E., Bendell, J., Algül, H., Rivera, F., Ahn, E.R., Watkins, D., Pelzer, U., Charu, V., Zalutskaya, A., Kuesters, G., Pipas, J.M., Santillana, S., Askoxylakis, V., Ko, A.H.
Published in Annals of oncology (01.08.2020)
Published in Annals of oncology (01.08.2020)
Get full text
Journal Article
A phase II clinical investigation of BPM31510-IV (ubidecarenone) in patients with advanced pancreatic cancer
Niewiarowska, A.A., Lucius, D.M., Sarangarajan, R., Narain, N.R., Ramanathan, R., Ritch, P., Strauss, J., Kundranda, M., Propper, D.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer
Ko, A.H., Cubillo, A., Kundranda, M., Zafar, S.F., Meiri, E., Bendell, J., Alguel, H., Rivera Herrero, F., Ahn, E., Watkins, D., Pelzer, U., Charu, V., Downing, W., Wang, B., Kuesters, G., Pipas, J.M., Santillana, S.L., Askoxylakis, V.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1884 The incidence and clinical significance of ESR1 mutations in patients with heavily pretreated metastatic breast cancer
Niu, J, Andres, G, Kramer, K, Kundranda, M, Weiss, G, Klimant, E, Parikh, A, Tan, B, Staren, E, Markman, M
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma
Kakadia, Sunilkumar, Yarlagadda, Naveen, Awad, Ramez, Kundranda, Madappa, Niu, Jiaxin, Naraev, Boris, Mina, Lida, Dragovich, Tomislav, Gimbel, Mark, Mahmoud, Fade
Published in OncoTargets and therapy (01.01.2018)
Published in OncoTargets and therapy (01.01.2018)
Get full text
Journal Article
717PCell-free tumour-DNA (cfDNA) as a very early predictor of therapeutic outcome in pancreatic ductal adenocarcinoma (PDAC)
Payr, S, Bergelin, J, Beck, J, Dragovich, T, Azizian, A, Brunner, M, König, U, Naraev, B, Ellenrieder, V, Gaedcke, J, Schütz, E, Kundranda, M N, König, A-O
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Corrigendum to ‘Randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer (CARRIE)’
Kundranda, M., Gracian, A.C., Zafar, S.F., Meiri, E., Bendell, J., Algül, H., Rivera, F., Ahn, E.R., Watkins, D., Pelzer, U., Charu, V., Zalutskaya, A., Kuesters, G., Pipas, J.M., Santillana, S., Askoxylakis, V., Ko, A.H.
Published in Annals of oncology (01.08.2020)
Published in Annals of oncology (01.08.2020)
Get full text
Journal Article
790TiPA phase II clinical investigation of BPM31510-IV (ubidecarenone) in patients with advanced pancreatic cancer
Niewiarowska, A A, Lucius, D M, Sarangarajan, R, Narain, N R, Ramanathan, R, Ritch, P, Strauss, J, Kundranda, M, Propper, D
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
LBA29CARRIE: A randomized, double-blind, placebo-controlled phase II study of istiratumab (MM-141) plus nab-paclitaxel and gemcitabine versus nab-paclitaxel and gemcitabine in front-line metastatic pancreatic cancer
Ko, A H, Cubillo, A, Kundranda, M, Zafar, S F, Meiri, E, Bendell, J, Alguel, H, Rivera Herrero, F, Ahn, E, Watkins, D, Pelzer, U, Charu, V, Downing, W, Wang, B, Kuesters, G, Pipas, J M, Santillana, S L, Askoxylakis, V
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
The association of metabolic syndrome with triple-negative breast cancer
Maiti, B., Kundranda, M. N., Jin, T., Spiro, T. P., Daw, H. A.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Gemcitabine and nab-paclitaxel in patients with unresectable/borderline resectable pancreatic cancer
Thapaliya, P., Kundranda, M. N., Curtis, K. K., Callister, M. D., Ashman, J. B., Collins, J., Moss, A., Mekeel, K. L., Silva, A. C., Borad, M. J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Shifting of patient characteristics enrolled on phase I clinical trials
Kundranda, M., Fu, P., Patrick, L., Manda, S., Gibbons, J., Dowlati, A.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Central nervous system metastases after trastuzumab therapy in patients with breast cancer
Daw Sr, H., Muslimani, A., Ahluwalia, M., Kundranda, M.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article
Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breastcancer patients
Niu J, Andres G, Kramer K, Kundranda MN, Alvarez RH, Klimant E, Parikh AR, Tan B, Staren ED, Markman M
Published in OncoTargets and therapy (01.11.2015)
Get full text
Published in OncoTargets and therapy (01.11.2015)
Journal Article